Skip to Content

Zimmer Biomet Holdings Inc ZIM

Morningstar Rating
$99.15 +0.23 (0.23%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ZIM is trading within a range we consider fairly valued.
Price
€99.74
Fair Value
€564.38
Uncertainty
High
1-Star Price
€295.45
5-Star Price
€93.25
Economic Moat
Skjhp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ZIM is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$98.92
Day Range
$99.1599.15
52-Week Range
$72.00149.00
Bid/Ask
$0.00 / $0.00
Market Cap
$20.40 Bil
Volume/Avg
0 / 27

Key Statistics

Price/Earnings (Normalized)
14.14
Price/Sales
3.01
Dividend Yield (Trailing)
0.92%
Dividend Yield (Forward)
0.90%
Total Yield
3.33%

Company Profile

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Core
Total Number of Employees
18,000

Competitors

Valuation

Metric
ZIM
JNJ
SNN
Price/Earnings (Normalized)
14.1413.9113.90
Price/Book Value
1.755.002.12
Price/Sales
3.014.091.99
Price/Cash Flow
11.6315.7311.75
Price/Earnings
ZIM
JNJ
SNN

Financial Strength

Metric
ZIM
JNJ
SNN
Quick Ratio
0.660.840.67
Current Ratio
1.661.171.77
Interest Coverage
5.8923.572.84
Quick Ratio
ZIM
JNJ
SNN

Profitability

Metric
ZIM
JNJ
SNN
Return on Assets (Normalized)
6.15%12.64%7.27%
Return on Equity (Normalized)
10.57%31.72%13.79%
Return on Invested Capital (Normalized)
8.26%20.11%9.92%
Return on Assets
ZIM
JNJ
SNN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LtszbhpFlgjch$180.4 Bil
Stryker Corp
SYK
PsbrmlflywQtqsf$131.4 Bil
Boston Scientific Corp
BSX
MqsfldxdZxmzsbf$112.9 Bil
Medtronic PLC
MDT
FhgmczgbPxcqyl$106.3 Bil
Edwards Lifesciences Corp
EW
ZcsjtxpmygNjbmtw$52.6 Bil
DexCom Inc
DXCM
DrwqrvvsxJvmr$45.9 Bil
Koninklijke Philips NV ADR
PHG
ScbqhjlPfjlw$24.3 Bil
Zimmer Biomet Holdings Inc
ZBH
WsbvtdprxRjnv$22.1 Bil
Steris PLC
STE
HhzcmwdVbmvfpt$21.6 Bil
Align Technology Inc
ALGN
ZtmgktylKvvcb$19.3 Bil

Sponsor Center